Shionogi & Co., Ltd. (TYO:4507)
2,894.50
+18.50 (0.64%)
Jul 21, 2026, 3:24 PM JST
Shionogi & Employees
Shionogi & had 6,223 employees as of March 31, 2026. The number of employees increased by 1,268 or 25.59% compared to the previous year.
Employees
6,223
Change (1Y)
1,268
Growth (1Y)
25.59%
Revenue / Employee
80.30M JPY
Profits / Employee
32.97M JPY
Market Cap
2.45T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 6,223 | 1,268 | 25.59% |
| Mar 31, 2025 | 4,955 | -4 | -0.08% |
| Mar 31, 2024 | 4,959 | -721 | -12.69% |
| Mar 31, 2023 | 5,680 | -13 | -0.23% |
| Mar 31, 2022 | 5,693 | 208 | 3.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Eisai | 10,543 |
| Sumitomo Pharma | 4,980 |
| Tsumura & Co. | 4,923 |
| Towa Pharmaceutical | 4,923 |
| Sawai Group Holdings | 3,630 |
| Nippon Shinyaku | 2,309 |
| Kissei Pharmaceutical | 1,786 |
Shionogi & News
- 4 days ago - FDA Accepts Shionogi's sNDA for Fetroja® (cefiderocol) for Use in Pediatric Patients with Serious Infections Caused by Susceptible Gram-negative Bacteria - Business Wire
- 27 days ago - Shionogi & Slides: Investor presentation - Filings
- 7 weeks ago - Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure - Business Wire
- 7 weeks ago - US regulator approves oral drug from Japan's Shionogi to prevent COVID-19 - Reuters
- 2 months ago - New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure - Business Wire
- 2 months ago - Shionogi & Quarterly report: Q4 2026 - Filings
- 2 months ago - Shionogi & Slides: Q4 2026 - Filings
- 3 months ago - Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats - Business Wire